131 related articles for article (PubMed ID: 33790078)
1. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
Xu J; Ma X; Yang H; Zhang J; Cai G; Yao N
Chem Pharm Bull (Tokyo); 2021; 69(4):325-332. PubMed ID: 33790078
[TBL] [Abstract][Full Text] [Related]
2. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
3. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
4. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.
Wufuer R; Ma HX; Luo MY; Xu KY; Kang L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102143. PubMed ID: 33307230
[TBL] [Abstract][Full Text] [Related]
6. MiR-142-3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer.
Xu T; He BS; Pan B; Pan YQ; Sun HL; Liu XX; Xu XN; Chen XX; Zeng KX; Xu M; Wang SK
J Cell Physiol; 2020 May; 235(5):4928-4940. PubMed ID: 31674013
[TBL] [Abstract][Full Text] [Related]
7. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
Chen R; Zhang L
Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Circ-CEP128 Enhances the Paclitaxel Sensitivity of Cervical Cancer Through Regulating miR-432-5p/MCL1.
Zhao Y; Lan Y; Chi Y; Yang B; Ren C
Biochem Genet; 2022 Dec; 60(6):2346-2363. PubMed ID: 35391656
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer.
Li X; Zhu J; Liu Y; Duan C; Chang R; Zhang C
Cancer Sci; 2019 Jun; 110(6):1883-1896. PubMed ID: 30955235
[TBL] [Abstract][Full Text] [Related]
10. CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
Dong M; Li P; Xie Y; Wang Z; Wang R
Drug Dev Res; 2021 Dec; 82(8):1193-1205. PubMed ID: 34046939
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
13. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
14. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.
Ling H; Ji X; Lei Y; Jia Y; Liu F; Xia H; Tan H; Zeng X; Yi L; He J; Su Q
Int J Oncol; 2020 Mar; 56(3):772-782. PubMed ID: 32124958
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
16. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
17. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.
Geng A; Luo L; Ren F; Zhang L; Zhou H; Gao X
BMC Cancer; 2021 Jul; 21(1):843. PubMed ID: 34289832
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0000119 promotes cervical cancer cell growth and migration via miR-433-3p/PAK2 axis.
Zhang J; Chu G; Zheng L; Liu J; He J
J Appl Genet; 2023 Sep; 64(3):531-543. PubMed ID: 37540462
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2.
Zhou L; Xu XL
Pathobiology; 2021; 88(4):301-312. PubMed ID: 33965958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
